Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Vistagen Therapeutics, Inc. (VTGN)

NASDAQ

$0.24

$-0.00

(-1.02%)

Previous Close: ⁦$0.25⁩

Market Closed

Vistagen Therapeutics, Inc. (VTGN) Live Price Chart

Last updated: ⁦2026-09-06 03:09:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Vistagen Therapeutics, Inc. (VTGN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.24, with a market capitalisation of $10.92M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.20 to $5.14. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$10.92M
Open	$0.25
Day's High	$140.70
Day's Low	$0.20
Previous Close	$0.25
Volume	344.59K
Average Volume	--
P/E Ratio	--
52-Week High	$5.14
52-Week Low	$0.20
Dividend Yield	--
Earnings Date	--

Vistagen Therapeutics, Inc. (VTGN) Latest Closing Stock Price

Vistagen Therapeutics, Inc. (VTGN) last closed at $0.25 as of 2026-09-04 23:57:00, unchanged from the previous close of $0.25.

During the latest regular trading session, VTGN traded between $0.20 and $140.70, with a volume of 344.59K shares. The closing price was near the lower end and near the lower end of its 52-week range.

Vistagen Therapeutics, Inc. (VTGN) 7-Day Stock Price Change

Over the past seven days, Vistagen Therapeutics, Inc. (VTGN) moved from $0.26 to $0.24, representing a decline of 5.43% ($0.01).

The stock traded between $0.24 and $0.26 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 379.47 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

VTGN 52-Week Price Position

Position in Range: 0.9%

52W Low$0.20

52W High$5.14

VTGN is currently trading at $0.24, placing it 0.9% of the way from its 52-week low of $0.20 to its 52-week high of $5.14. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Vistagen Therapeutics, Inc. (VTGN)?

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

Vistagen Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	41
Exchange	NASDAQ
Company Website	https://www.vistagen.com

How to Buy Vistagen Therapeutics, Inc. (VTGN) Stock on MEXC

Eligible investors can buy real shares of Vistagen Therapeutics, Inc. (VTGN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for VTGN and Place Your Order

Open the RealStocks trading page and search for VTGN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Vistagen Therapeutics, Inc. (VTGN) share price today?

Vistagen Therapeutics, Inc. (VTGN) is currently trading at $ 0.24, down 0.89% ($0.00) from the previous close of $ 0.25. Intraday prices update in real time during regular trading hours.

2.Is VTGN stock going up or down today?

As of 2026-09-04 23:57:00, VTGN is trading at $ 0.24, down 0.89% ($0.00) from its previous close of $ 0.25. The stock has traded between $ 0.20 and $ 140.70 during today’s regular session. Past price movements do not guarantee future results.

3.What is VTGN pre-market price?

As of 2026-09-04 23:57:00, VTGN is trading at $ 0.25 in pre-market trading, down 0.08% ($0.00) from the previous close of $ 0.25. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is VTGN after-hours price?

As of 2026-09-04 23:57:00, VTGN is trading at $ 0.25 in after-hours trading, up 0.73% ($0.00) from the regular-session close of $ 0.25. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is VTGN stock trading now?

VTGN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does VTGN sit relative to its 52-week high and low?

Over the past 52 weeks, VTGN has traded between a low of $ 0.20 and a high of $ 5.14. At $ 0.24, the stock is positioned 0.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Vistagen Therapeutics, Inc. in?

Vistagen Therapeutics, Inc. (VTGN) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Vistagen Therapeutics, Inc.'s market capitalisation and where is it listed?

Vistagen Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 10.92M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is VTGN valued in terms of P/E ratio and EPS?

VTGN trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.52. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Vistagen Therapeutics, Inc. pay a dividend?

Vistagen Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.